Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.

Moderna Inc. said its COVID-19 vaccine remained 93% effective six months after the second shot as it reported second-quarter earnings and revenue that beat expectations.

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

Moderna’s Covid Vaccine: What You Need to Know. By Carl Zimmer and Denise Grady. Published Nov. 16, 2020 Updated Nov. 30, 2020. Share full article. Image.

Moderna early data shows coronavirus vaccine is nearly 95% effective 03:57. For the second time this month, there's promising news from a COVID-19 vaccine candidate.

Moderna Inc. Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study. Posted online November 16, 2020.

Clinical data for Moderna's COVID-19 vaccine showed it was nearly 95% effective in preventing disease, according to an interim analysis described in a company release Monday.

Moderna is the second company to report encouraging results for its coronavirus vaccine candidate, saying its shot is 94.5% effective. Sign Up for Our Ideas Newsletter POV Subscribe Subscribe ...

Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.